Long-term safety and efficacy of Neoral in heart transplantation.
Yonan
N A
NA
Department Cardiothoracic Surgery, Wythenshawe Hospital, Manchester, United Kingdom.
Aziz
T
T
el-Gamel
A
A
Campbell
C S
CS
Rahman
A N
AN
Deiraniya
A K
AK
D000284:Administration, Oral; D000328:Adult; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D016040:Lung Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors
D004232:Diuretics; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine